Orientation to Ependymoma: The Basics
At a Glance
An ependymoma is a rare primary tumor of the central nervous system that begins in the brain or spinal cord. Initial steps after diagnosis typically involve full spine and brain imaging, surgical resection, and molecular subtyping to guide a personalized treatment plan.
Receiving a diagnosis of ependymoma—a rare tumor of the central nervous system—can feel overwhelming. It is important to know that you are not alone and that significant progress has been made in understanding how these tumors form and how to treat them. This page provides a starting point to help you understand the nature of the disease and how doctors categorize it.
What is Ependymoma?
An ependymoma is a type of primary tumor that begins in the brain or spinal cord [1]. It is called “primary” because it starts in the central nervous system rather than spreading there from another part of the body [1].
These tumors arise from ependymal cells, which are specialized cells that line the ventricles (fluid-filled spaces) in the brain and the central canal of the spinal cord [2]. In a healthy body, these cells help produce and circulate cerebrospinal fluid (CSF), the clear liquid that cushions the brain and spine [2]. When an ependymoma forms, these cells grow abnormally, creating a mass that can press on sensitive nerve tissues [3].
Where Do These Tumors Form?
Doctors classify ependymomas into three main anatomical locations, as the tumor’s position determines both the symptoms a patient experiences and the treatment options available [2]:
- Supratentorial: Located in the upper part of the brain (the cerebrum). These often cause symptoms like headaches or seizures [2].
- Posterior Fossa (Infratentorial): Located at the back of the brain near the brainstem and cerebellum. This is the most common site for children and often affects balance and coordination [4][2].
- Spinal: Located along the spinal cord. These are more common in adults and often cause back pain or weakness in the limbs [4][2].
Who is Affected?
Ependymoma can occur at any age, but it shows different patterns in children versus adults.
- In Children: It is one of the most common brain tumors in childhood, accounting for about 9% of pediatric brain and spine tumors [2]. Most pediatric cases occur in the posterior fossa (the back of the head) [4].
- In Adults: While rarer overall, adults are more likely to develop ependymomas in the spinal cord [4].
Recent data shows that the recorded incidence of ependymoma has increased slightly over the last two decades. This is likely due to better diagnostic tools and more precise reporting [5].
What Causes Ependymoma?
For most families, the cause of the tumor remains unknown. It is rarely “inherited” in the traditional sense; less than 4% of childhood cases are linked to known hereditary genetic syndromes, such as Neurofibromatosis type 2 (NF2) [6]. There are currently no confirmed environmental or lifestyle factors that cause these tumors [7].
Modern medicine has moved toward molecular profiling, which looks at the genetic “fingerprint” of the tumor [8]. We now know there are at least nine distinct molecular subgroups of ependymoma [8]. This means that two tumors in the same location might behave very differently based on their molecular makeup [9].
Navigating the Diagnosis
It is completely normal to experience a wide range of emotions, including fear, anxiety, and depression, following a diagnosis [10]. Because ependymoma is rare, it is essential to work with a specialized multidisciplinary neuro-oncology team that understands these specific subtypes [8].
The path forward usually begins with a focus on three key steps:
- Staging the Disease: Because ependymomas can spread through the cerebrospinal fluid (CSF), your team will require a full MRI of both the brain and spine, and potentially a lumbar puncture (spinal tap), to check for any spread before finalizing your treatment plan [2].
- The Extent of Surgical Resection: Removing as much of the tumor as safely possible is often the most critical first step [11][3].
- Molecular Subtyping: Identifying the specific group of the tumor to help the care team predict its behavior and tailor the treatment plan [9][12].
This orientation is your first step in becoming an informed advocate for your or your child’s care. To continue learning, explore how tumors are categorized in the Ependymoma Subtypes and the 2021 WHO Classification, how to read your medical records in Decoding Your Pathology and Surgical Reports, or dive straight into Standard of Care: Surgery, Radiation, and Trials.
In this guide
4 chapters
Ependymoma Subtypes and the 2021 WHO Classification
Learn about the 2021 WHO classification of ependymoma subtypes. Understand what molecular profiling, ZFTA fusions, and PFA or PFB groups mean for your care.
Decoding Your Pathology and Surgical Reports
Learn how to read your ependymoma pathology and surgical reports. Understand gross total resection, DNA methylation, and molecular subgroup results.
Standard of Care: Surgery, Radiation, and Trials
Learn about the standard of care for ependymoma, including gross total resection, proton vs. photon radiation therapy, and when chemotherapy is used.
Prognosis, Risk Stratification, and Life After Treatment
Understand ependymoma prognosis, risk stratification, and life after treatment. Learn how molecular subtypes, surgical success, and MRIs impact survival.
Common questions in this guide
What is an ependymoma?
Where do ependymomas usually grow?
Are ependymoma brain tumors hereditary?
Why do I need a full MRI and spinal tap for an ependymoma diagnosis?
What is molecular subtyping for ependymoma?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the specific anatomical location of the tumor (supratentorial, posterior fossa, or spinal)?
- 2.Has molecular subtyping or DNA methylation profiling been performed on the tumor sample?
- 3.Are you planning a full MRI of the brain and spine, as well as a lumbar puncture, to check for tumor spread?
- 4.What is the WHO grade of this tumor, and how does that influence the plan for surgery or radiation?
- 5.Are there specialized support services, like child life specialists or neuro-oncology social workers, available for our family?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions.
Lim-Fat MJ, Bennett J, Ostrom Q, et al.
Neuro-oncology 2025; (27(1)):13-32 doi:10.1093/neuonc/noae186.
PMID: 39441704 - 2
Ependymal Tumors.
Thomas AG, Chattopadhyay A, Dineen RA
Neuroimaging clinics of North America 2026; (36(1)):69-83 doi:10.1016/j.nic.2025.08.008.
PMID: 41274771 - 3
The association between postoperative photon radiotherapy dose and disease control and salvage treatment in pediatric and adolescent ependymoma: a multi-institutional investigation.
Liu KX, Salans M, Easwaran TP, et al.
Journal of neuro-oncology 2025; (173(1)):167-177 doi:10.1007/s11060-025-04975-5.
PMID: 39998722 - 4
Cerebellopontine angle ependymoma in a young adult: A case report.
Lan Z, Richard SA, Zhang Y
Medicine 2019; (98(14)):e15019 doi:10.1097/MD.0000000000015019.
PMID: 30946332 - 5
Descriptive Epidemiology of Ependymal Tumors in Gironde, France: Results from the Gironde Registry for the 2000-2018 Period.
Laine G, Baldi I, Jecko V, et al.
Neuroepidemiology 2022; (56(4)):250-260 doi:10.1159/000523954.
PMID: 35320802 - 6
Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort.
Foss-Skiftesvik J, Stoltze UK, van Overeem Hansen T, et al.
Acta neuropathologica communications 2022; (10(1)):123 doi:10.1186/s40478-022-01429-1.
PMID: 36008825 - 7
Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma.
Zhang C, Ostrom QT, Semmes EC, et al.
Acta neuropathologica communications 2020; (8(1)):173 doi:10.1186/s40478-020-01038-w.
PMID: 33115534 - 8
[Ependymoma in WHO Classification of Tumours 5th Edition].
Saito R
No shinkei geka. Neurological surgery 2023; (51(5)):867-875 doi:10.11477/mf.1436204828.
PMID: 37743338 - 9
Ependymal Tumors: Overview of the Recent World Health Organization Histopathologic and Genetic Updates with an Imaging Characteristic.
Soni N, Ora M, Bathla G, et al.
AJNR. American journal of neuroradiology 2024; (45(11)):1624-1634 doi:10.3174/ajnr.A8237.
PMID: 38844368 - 10
Longitudinal Psychological Distress After Malignant Brain Tumor Diagnosis: A Multilevel Analysis of Patients and Their Caregivers.
Karger A, Kisić AM, Quente C, et al.
Psycho-oncology 2025; (34(1)):e70064 doi:10.1002/pon.70064.
PMID: 39794295 - 11
Nationwide Brain Tumor Registry-based Study of Adult Intracranial Ependymoma in Japan.
Yamazawa E, Tanaka S, Takayanagi S, et al.
Neurologia medico-chirurgica 2025; (65(9)):373-379 doi:10.2176/jns-nmc.2025-0037.
PMID: 40803843 - 12
Advances in molecular prognostication and treatments in ependymoma.
Bakes E, Cheng R, Mañucat-Tan N, et al.
Journal of neuro-oncology 2025; (172(2)):317-326 doi:10.1007/s11060-024-04923-9.
PMID: 39757304
This page provides basic educational information about ependymoma and its diagnosis. It is not a substitute for professional medical advice from a specialized neuro-oncology team.
Get notified when new evidence is published on Ependymal tumor.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.